Skip to main content
. Author manuscript; available in PMC: 2017 Sep 8.
Published in final edited form as: Abdom Radiol (NY). 2017 Jun;42(6):1685–1694. doi: 10.1007/s00261-017-1066-y

Table 3.

Imaging findings.

RE TACE/RFA Untreated Liver p
Lesion size (mean ± SD) [cm] 3.2 ± 1.2 3.0 ± 1.4 3.8 ± 2.6 - 0.886
TS/LS (mean ± SD) [kPa] 3.8 ± 1.9 4.3 ± 1.9 6.9 ± 3.4 5.3 ± 2.2 10.002
20.008
30.725
40.004
50.006
60.726

Footnote

1

RE vs. Untreated;

2

TACE/RFA vs. Untreated;

3

RE vs. TACE/RFA;

4

RE vs. Liver;

5

TACE/RFA vs. Liver;

6

Untreated vs. Liver

Significant p-values are bolded

RE, radioembolization; TACE/RFA, transarterial chemoembolization plus radiofrequency ablation; TS, tumor stiffness; LS, liver stiffness